Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
VanEck Oil Services ETF
OIH
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
US Stock MarketDetailed Quotes
MEDIPHARM LABS CORP (MEDIF)
- 0.0495
- -0.0005-1.00%
15min DelayClose Apr 24 15:56 ET
21.03MMarket Cap-3.30P/E (TTM)
0.0504High0.0486Low25.31KVolume0.0504Open0.0500Prev Close1.25KTurnover0.01%Turnover RatioLossP/E (Static)424.86MShares0.080652wk High0.80P/B21.03MFloat Cap0.041552wk Low--Dividend TTM424.86MShs Float0.4730Historical High--Div Yield TTM3.60%Range %0.0374Historical Low0.0493Avg Price1Lot Size
MEDIPHARM LABS CORP (MEDIF) Cash Flow
Quarterly+Annual
YOY
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -13.23%-5.5M | 140.77%435K | 76.13%-158K | -72.42%-2.77M | -97.38%-3.01M | 60.60%-4.86M | -172.39%-1.07M | 79.52%-662K | 78.67%-1.61M | 49.98%-1.53M |
| Net income from continuing operations | 22.69%-8.27M | -14.02%-1.97M | 22.78%-2.14M | -45.95%-3.77M | 89.28%-387K | 18.26%-10.69M | 38.07%-1.73M | 35.89%-2.77M | 10.34%-2.58M | -16.94%-3.61M |
| Operating gains losses | 71.76%-98K | 277.78%16K | 7,200.00%146K | -1,085.71%-249K | 96.55%-11K | -229.00%-347K | 10.00%-9K | -94.74%2K | -108.90%-21K | -6,480.00%-319K |
| Depreciation and amortization | -36.15%1.66M | -29.41%396K | -18.92%420K | -42.68%419K | -46.20%425K | 3.34%2.6M | -21.76%561K | -16.05%518K | 5.64%731K | 61.22%790K |
| Other non cash items | -200.88%-574K | -27.69%-166K | -131.62%-185K | -168.33%-123K | -51.52%-100K | 107.75%569K | 62.75%-130K | 137.07%585K | 103.48%180K | 73.06%-66K |
| Change In working capital | -101.51%-25K | 110.72%1.73M | 56.04%1.37M | 147.30%272K | -743.37%-3.4M | -52.12%1.65M | -73.65%821K | -31.83%878K | 62.66%-575K | -9.90%528K |
| -Change in receivables | 95.97%-63K | 120.43%162K | 160.47%286K | -172.10%-230K | 54.38%-281K | -124.35%-1.56M | -113.74%-793K | -105.65%-473K | -64.56%319K | -2,700.00%-616K |
| -Change in inventory | 45.55%965K | -69.24%191K | 745.73%1.39M | 999.12%1.25M | -690.68%-1.87M | -79.71%663K | 99.68%621K | -92.61%164K | 124.73%114K | -119.70%-236K |
| -Change in payables and accrued expense | -65.18%650K | 1,496.77%495K | -94.21%32K | 14.81%-512K | -66.30%635K | 136.14%1.87M | 102.45%31K | 146.04%553K | 68.43%-601K | 336.68%1.88M |
| -Change in other current assets | -26.84%199K | -31.26%288K | -29.03%308K | 33.59%-595K | -37.14%198K | 122.28%272K | 127.57%419K | -46.75%434K | -45.45%-896K | 215.00%315K |
| -Change in other working capital | -530.02%-1.78M | 9.39%594K | -421.50%-643K | -27.20%356K | -154.33%-2.08M | 175.33%413K | 398.35%543K | 163.49%200K | --489K | -872.64%-819K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -13.23%-5.5M | 140.77%435K | 76.13%-158K | -72.42%-2.77M | -97.38%-3.01M | 60.60%-4.86M | -172.39%-1.07M | 79.52%-662K | 78.67%-1.61M | 49.98%-1.53M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 1,018.64%4.62M | 0 | 1,490.91%459K | 12,108.57%4.2M | -108.00%-42K | -93.99%413K | -101.02%-44K | -102.01%-33K | -103.70%-35K | 2,200.00%525K |
| Capital expenditure reported | ---- | ---- | 51.52%-16K | 25.00%-42K | -100.00%-42K | 67.30%-154K | 63.03%-44K | 87.31%-33K | 16.42%-56K | 16.00%-21K |
| Net PPE purchase and sale | -133.68%-65K | 35.06%-100K | --35K | --0 | --0 | 8.43%193K | -186.52%-154K | --0 | --21K | --326K |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net other investing changes | 2,029.55%4.69M | --0 | --440K | ---- | ---- | -88.44%220K | --0 | ---- | --0 | --220K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 1,018.64%4.62M | --0 | 1,490.91%459K | 12,108.57%4.2M | -108.00%-42K | -93.99%413K | -101.02%-44K | -102.01%-33K | -103.70%-35K | 2,200.00%525K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 99.03%-18K | 25.00%-183K | 96.71%-73K | -34.74%447K | -216.67%-209K | -401.90%-1.85M | -1.24%-244K | -643.14%-2.22M | -37.21%685K | 92.82%-66K |
| Net issuance payments of debt | 91.47%-192K | 33.83%-223K | 94.65%-120K | -30.20%416K | 1.49%-265K | -138.56%-2.25M | 13.81%-337K | -477.84%-2.24M | -40.40%596K | 76.91%-269K |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | --0 | ---- | ---- | ---- | ---- | --14K | ---- | ---- | ---- | ---- |
| Net other financing activities | -66.43%232K | -40.82%58K | -63.31%62K | -79.00%42K | -68.75%70K | -17.74%691K | -56.83%98K | -2.87%169K | 5.82%200K | -10.40%224K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 99.03%-18K | 25.00%-183K | 96.71%-73K | -34.74%447K | -216.67%-209K | -401.90%-1.85M | -1.24%-244K | -643.14%-2.22M | -37.21%685K | 92.82%-66K |
| Net cash flow | ||||||||||
| Beginning cash position | -34.99%11.69M | -19.16%10.58M | -35.20%10.36M | -50.12%8.44M | -34.99%11.69M | -25.53%17.98M | 1.10%13.09M | 8.47%15.99M | -16.00%16.93M | -25.53%17.98M |
| Current changes in cash | 85.67%-902K | 118.60%252K | 107.82%228K | 296.76%1.88M | -205.81%-3.26M | -7.88%-6.3M | -124.45%-1.36M | -54.50%-2.92M | 82.60%-956K | 73.29%-1.07M |
| Effect of exchange rate changes | 350.00%18K | 36.17%-30K | -133.33%-6K | 80.95%38K | 33.33%16K | 101.22%4K | 90.78%-47K | -81.25%18K | -75.29%21K | --12K |
| End cash Position | -7.56%10.81M | -7.56%10.81M | -19.16%10.58M | -35.20%10.36M | -50.12%8.44M | -34.99%11.69M | -34.99%11.69M | 1.10%13.09M | 8.47%15.99M | -16.00%16.93M |
| Free cash flow | -11.74%-5.6M | 139.15%435K | 74.96%-174K | -69.13%-2.81M | -97.41%-3.05M | 60.85%-5.02M | -181.99%-1.11M | 80.10%-695K | 78.12%-1.66M | 49.71%-1.55M |
| Currency Unit | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm